Positive Correlation of Peripheral CD8(+) T Lymphocytes with Immune-Related Adverse Events and Combinational Prognostic Value in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors

SIMPLE SUMMARY: Immune checkpoint inhibitors are widely used in clinical practice and have demonstrated remarkable efficacy in advanced non-small cell lung cancer (NSCLC). However, their use is also commonly accompanied by immune-related adverse events (irAEs), and markers that are able to predict t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Kan, Xia, Bing, Zhang, Jing, Li, Xin, Yang, Shaoyu, Zhang, Minna, Zhu, Lucheng, Wang, Bing, Xu, Xiao, Ma, Shenglin, Chen, Xueqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331848/
https://www.ncbi.nlm.nih.gov/pubmed/35892826
http://dx.doi.org/10.3390/cancers14153568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331848/
https://www.ncbi.nlm.nih.gov/pubmed/35892826
http://dx.doi.org/10.3390/cancers14153568

Ejemplares similares